trial · primary record
BMS-986278
Pulmonary Fibrosis
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 2380 |
| Primary completion | 2030-03-30 |
| Primary endpoint | Number of Participants With Treatment Emergent Adverse Events (TEAEs) |
| Registry ID | NCT07441408 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:42:52.364Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07441408
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.